HomeCompareCYBF vs MRK

CYBF vs MRK: Dividend Comparison 2026

CYBF yields 666666.67% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CYBF wins by $8.275235618773884e+34M in total portfolio value
10 years
CYBF
CYBF
● Live price
666666.67%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8.275235618773884e+34M
Annual income
$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00
Full CYBF calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — CYBF vs MRK

📍 CYBF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCYBFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CYBF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CYBF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CYBF
Annual income on $10K today (after 15% tax)
$56,666,666.67/yr
After 10yr DRIP, annual income (after tax)
$70,318,753,614,835,575,000,000,000,000,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, CYBF beats the other by $70,318,753,614,835,575,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CYBF + MRK for your $10,000?

CYBF: 50%MRK: 50%
100% MRK50/50100% CYBF
Portfolio after 10yr
$4.137617809386942e+34M
Annual income
$41,363,972,714,609,160,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.97%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CYBF
No analyst data
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CYBF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCYBFMRK
Forward yield666666.67%2.81%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$8.275235618773884e+34M$57.7K
Annual income after 10y$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00$10,113.78
Total dividends collected$8.275075881065991e+34M$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CYBF vs MRK ($10,000, DRIP)

YearCYBF PortfolioCYBF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$66,677,367$66,666,666.67$11,213$373.04+$66.67MCYBF
2$415,506,651,117$415,435,306,334.37$12,667$512.06+$415506.64MCYBF
3$2,419,908,598,386,268$2,419,464,006,269,573.00$14,439$708.14+$2419908598.37MCYBF
4$13,171,697,643,084,456,000$13,169,108,340,884,183,000.00$16,640$988.16+$13171697643084.44MCYBF
5$67,004,927,492,790,120,000,000$66,990,833,776,312,020,000,000.00$19,432$1,394.07+$67004927492790120.00MCYBF
6$318,562,277,003,514,840,000,000,000$318,490,581,731,097,560,000,000,000.00$23,057$1,992.90+$318562277003514871808.00MCYBF
7$1,415,484,168,853,553,000,000,000,000,000$1,415,143,307,217,159,200,000,000,000,000.00$27,889$2,894.79+$1.415484168853553e+24MCYBF
8$5,878,130,573,362,507,000,000,000,000,000,000$5,876,616,005,301,833,000,000,000,000,000,000.00$34,518$4,286.29+$5.878130573362507e+27MCYBF
9$22,813,793,009,840,743,000,000,000,000,000,000,000$22,807,503,410,127,248,000,000,000,000,000,000,000.00$43,912$6,494.35+$2.2813793009840744e+31MCYBF
10$82,752,356,187,738,840,000,000,000,000,000,000,000,000$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00$57,714$10,113.78+$8.275235618773884e+34MCYBF

CYBF vs MRK: Complete Analysis 2026

CYBFStock

Cyberfort Software, Inc. develops, markets, and acquires software security technology. The company intends to acquire technologies to deal with the various and increasing cyber threats for mobile, personal, and business tech devices across various available platforms. It focuses on providing Just content, an iOS 11 moblie security app that acts as secure content blocker; and Vivio, an iOS 10 app that removes ads from the Websites and saves data traffic. The company was formerly known as Patriot Berry Farms, Inc. and changed its name to Cyberfort Software, Inc. in November 2016. Cyberfort Software, Inc. was founded in 2010 and is based in San Francisco, California.

Full CYBF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this CYBF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CYBF vs SCHDCYBF vs JEPICYBF vs OCYBF vs KOCYBF vs MAINCYBF vs JNJCYBF vs ABBVCYBF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.